US 12,268,759 B2
Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
John W. Babich, New York, NY (US); James M. Kelly, New York, NY (US); Alejandro Amor-Coarasa, New York, NY (US); and Shashikanth Ponnala, New York, NY (US)
Assigned to Cornell University, Ithaca, NY (US)
Filed by Cornell University, Ithaca, NY (US)
Filed on Oct. 11, 2022, as Appl. No. 17/963,823.
Application 17/016,189 is a division of application No. 16/134,789, filed on Sep. 18, 2018, granted, now 10,806,806.
Application 17/963,823 is a continuation of application No. 17/016,189, filed on Sep. 9, 2020.
Application 16/134,789 is a continuation in part of application No. PCT/US2018/026340, filed on Apr. 5, 2018.
Application 16/134,789 is a continuation in part of application No. 15/630,808, filed on Jun. 22, 2017, granted, now 10,179,117.
Claims priority of provisional application 62/574,720, filed on Oct. 19, 2017.
Claims priority of provisional application 62/482,038, filed on Apr. 5, 2017.
Claims priority of provisional application 62/353,735, filed on Jun. 23, 2016.
Prior Publication US 2023/0285603 A1, Sep. 14, 2023
Int. Cl. A61K 51/04 (2006.01); A61P 35/00 (2006.01)
CPC A61K 51/0482 (2013.01) [A61K 51/0402 (2013.01); A61K 51/0497 (2013.01); A61P 35/00 (2018.01)] 1 Claim
 
1. A compound that is

OG Complex Work Unit Chemistry
chelating 177Lu3+.